Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 160
Filter
1.
Sci Rep ; 11(1): 19293, 2021 09 29.
Article in English | MEDLINE | ID: mdl-34588566

ABSTRACT

It is widely acknowledged that efficiency of pediatric critical care transport plays a vital role in treatment of critically-ill children. In developing countries, most critically-ill children were transported by ambulance, and a few by air, such as a helicopter or fixed airplane. High-speed train (HST) transport may be a potential choice for critically-ill children to a tertiary medical center for further therapy. This is a single-center, retrospective cohort study from June 01, 2016 to June 30, 2019. All the patients transported to the Pediatric Intensive Care Unit (PICU) of PLA general hospital were divided into two groups, HST group and ambulance group. The propensity score matching method was performed for the comparison between the two groups. Finally, a 2:1 patient matching was performed using the nearest-neighbor matching method without replacement. The primary outcome was hospital mortality. Secondary outcomes included duration of transport, transport cost, hospital stay, and hospitalization cost. A total of 509 critically-ill children were transported and admitted. Of them, 40 patients were transported by HST, and 469 by ambulance. The hospital mortality showed no difference between the two groups (p > 0.05). The transport distance in the HST group was longer than that in the ambulance group (1894.5 ± 907.09 vs. 902.66 ± 735.74, p < 0.001). However, compared to the HST group, the duration of transport time by ambulance was significantly longer (p < 0.001). No difference in vital signs, blood gas analysis, and critical illness score between groups at admission was noted (p > 0.05). There was no death during the transport. There was no difference between groups regarding the transport cost, hospital stays, and hospitalization cost (p > 0.05). High-quality tertiary medical centers are usually located in megacities. HST transport network for critically-ill children could be established to cover most regions of the country. Without increasing financial burden, HST medical transport can be a potentially promising option to improve the outcomes of critically-ill children in developing countries with developed HST network.Clinical Trial Registration: This study was registered at http://www.chictr.org.cn/index.aspx (chiCTR.gov; Identifier: ChiCTR2000032306).


Subject(s)
Critical Illness/mortality , Intensive Care Units, Pediatric/statistics & numerical data , Railroads , Transportation of Patients/methods , Adolescent , Child , Child, Preschool , Critical Illness/economics , Female , Hospital Mortality , Humans , Infant , Infant, Newborn , Intensive Care Units, Pediatric/economics , Length of Stay/economics , Length of Stay/statistics & numerical data , Male , Propensity Score , Retrospective Studies , Time Factors , Transportation of Patients/economics , Transportation of Patients/statistics & numerical data
3.
J Perinat Med ; 49(5): 630-631, 2021 Jun 25.
Article in English | MEDLINE | ID: mdl-33544995

ABSTRACT

OBJECTIVES: Infants receiving care from neonatal intensive care unit (NICU) can develop chronic problems and be transferred to a paediatric intensive care unit (PICU) for on-going care. There is concern that such infants may take up a large amount of PICU resource, but this is not evidence based. We determined the impact of such transfers. METHODS: We reviewed 10 years of NICU admissions to two tertiary PICUs, which had approximately 12,000 admissions during that period. RESULTS: Sixty-seven infants, gestational age at birth 34.7 (IQR 27.1-38.8) weeks and postnatal age on transfer 81 (IQR 9-144) days were admitted from NICUs. The median (IQR) length of stay was 12 (4-41) days. The 19 infants born <28 weeks of gestation had a greater median length of stay (32, range IQR 10-93 days) than more mature born infants (7.5, IQR 4-26 days) (p=0.003). The median cost of PICU stay for NICU transfers was £23,800 (range 1,205-1,034,000) per baby. The total cost of care for infants transferred from NICUs was £6,457,955. CONCLUSIONS: Infants transferred from NICUs were a small proportion of PICU admissions but, particularly those born <28 weeks of gestation, had prolonged stays which needs to be considered when determining bed capacity.


Subject(s)
Hospital Costs/statistics & numerical data , Intensive Care Units, Neonatal/statistics & numerical data , Intensive Care Units, Pediatric , Intensive Care, Neonatal , Patient Transfer , Costs and Cost Analysis , Gestational Age , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Infant , Infant, Newborn , Infant, Premature , Intensive Care Units, Pediatric/economics , Intensive Care Units, Pediatric/statistics & numerical data , Intensive Care, Neonatal/methods , Intensive Care, Neonatal/organization & administration , Length of Stay/statistics & numerical data , Male , Patient Transfer/economics , Patient Transfer/methods , United Kingdom/epidemiology
4.
J Vasc Access ; 22(2): 184-188, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32564667

ABSTRACT

BACKGROUND: Placement of central venous access devices is a clinical procedure associated with some risk of adverse events and with a relevant cost. Careful choice of the device, appropriate insertion technique, and proper management of the device are well-known strategies commonly adopted to achieve an optimal clinical result. However, the environment where the procedure takes place may have an impact on the overall outcome in terms of safety and cost-effectiveness. METHODS: We carried out a retrospective analysis on pediatric patients scheduled for a major neurosurgical operation, who required a central venous access device in the perioperative period. We divided the patients in two groups: in group A the central venous access device was inserted in the operating room, while in group B the central venous access device was inserted in the sedation room of our Pediatric Intensive Care Unit. We compared the two groups in terms of safety and cost-effectiveness. RESULTS: We analyzed 47 central venous access devices in 42 children. There were no insertion-related complications. Only one catheter-related bloodstream infection was recorded, in group A. However, the costs related to central venous access device insertion were quite different: €330-€540 in group A versus €105-€135 in group B. CONCLUSION: In the pediatric patient candidate to a major neurosurgical operation, preoperative insertion of the central venous access device in the sedation room rather than in the operating room is less expensive and equally safe.


Subject(s)
Catheterization, Central Venous/instrumentation , Catheters, Indwelling , Central Venous Catheters , Intensive Care Units, Pediatric , Operating Rooms , Preoperative Care/instrumentation , Adolescent , Catheter-Related Infections/etiology , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/economics , Catheters, Indwelling/economics , Central Venous Catheters/economics , Child , Child, Preschool , Cost Savings , Cost-Benefit Analysis , Female , Hospital Costs , Humans , Infant , Intensive Care Units, Pediatric/economics , Male , Operating Rooms/economics , Preoperative Care/adverse effects , Preoperative Care/economics , Retrospective Studies , Young Adult
5.
Laryngoscope ; 131 Suppl 1: S1-S10, 2021 01.
Article in English | MEDLINE | ID: mdl-32438522

ABSTRACT

OBJECTIVE: Pediatric patients undergoing surgery on the aerodigestive tract require a wide range of postoperative airway support that may be difficult predict in the preoperative period. Inaccurate prediction of postoperative resource needs leads to care inefficiencies in the form of unanticipated intensive care unit (ICU) admissions, ICU bed request cancellations, and overutilization of ICU resources. At our hospital, inefficient utilization of pediatric intensive care unit (PICU) resources was negatively impacting safety, access, throughput, and finances. We hypothesized that actionable key drivers of inefficient ICU utilization at our hospital were operative scheduling errors and the lack of predictability of intermediate-risk patients and that improvement methodology could be used in iterative cycles to enhance efficiency of care. Through testing this hypothesis, we aimed to provide a framework for similar efforts at other hospitals. STUDY DESIGN: Quality improvement initiative. METHODS: Plan, Do, Study, Act methodology (PDSA) was utilized to implement two cycles of change aimed at improving level-of-care efficiency at an academic pediatric hospital. In PDSA cycle 1, we aimed to address scheduling errors with surgical order placement restriction, creation of a standardized list of surgeries requiring PICU admission, and implementation of a hard stop for postoperative location in the electronic medical record surgical order. In the PDSA cycle 2, a new model of care, called the Grey Zone model, was designed and implemented where patients at intermediate risk of airway compromise were observed for 2-5 hours in the post-anesthesia care unit. After this observation period, patients were then transferred to the level of care dictated by their current status. Measures assessed in PDSA cycle 1 were unanticipated ICU admissions and ICU bed request cancellations. In addition to continued analysis of these measures, PDSA cycle 2 measures were ICU beds avoided, safety events, and secondary transfers from extended observation to ICU. RESULTS: In PDSA cycle 1, no significant decrease in unanticipated ICU admissions was observed; however, there was an increase in average monthly ICU bed cancellations from 36.1% to 45.6%. In PDSA cycle 2, average monthly unanticipated ICU admissions and cancelled ICU bed requests decreased from 1.3% to 0.42% and 45.6% to 33.8%, respectively. In patients observed in the Grey Zone, 229/245 (93.5%) were transferred to extended observation, avoiding admission to the ICU. Financial analysis demonstrated a charge differential to payers of $1.1 million over the study period with a charge differential opportunity to the hospital of $51,720 for each additional hospital transfer accepted due to increased PICU bed availability. CONCLUSIONS: Implementation of the Grey Zone model of care improved efficiency of ICU resource utilization through reducing unanticipated ICU admissions and ICU bed cancellations while simultaneously avoiding overutilization of ICU resources for intermediate-risk patients. This was achieved without compromising safety of patient care, and was financially sound in both fee-for-service and value-based reimbursement models. While such a model may not be applicable in all healthcare settings, it may improve efficiency at other pediatric hospitals with high surgical volume and acuity. LEVEL OF EVIDENCE: N/A Laryngoscope, 131:S1-S10, 2021.


Subject(s)
Health Care Rationing/methods , Hospitals, Pediatric/organization & administration , Intensive Care Units, Pediatric/organization & administration , Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures , Postoperative Care/economics , Child , Health Care Rationing/economics , Health Care Rationing/statistics & numerical data , Health Plan Implementation/organization & administration , Hospitals, Pediatric/economics , Hospitals, Pediatric/statistics & numerical data , Humans , Intensive Care Units, Pediatric/economics , Intensive Care Units, Pediatric/statistics & numerical data , Otorhinolaryngologic Diseases/economics , Postoperative Care/statistics & numerical data , Program Evaluation , Quality Improvement
7.
Curr Opin Pediatr ; 32(3): 424-427, 2020 06.
Article in English | MEDLINE | ID: mdl-32332332

ABSTRACT

PURPOSE OF REVIEW: The purpose of this review is to describe quality and financial economic principles that form the foundation for complex care delivery systems for the critically ill pediatric surgical population. RECENT FINDINGS: Advances in neonatology along with innovation in surgical techniques in children led to the need to care for more complex postoperative surgical patients. Several studies have demonstrated improved outcomes in specialized pediatric centers. Furthermore, there is some evidence to suggest that there is overall financial benefit with decreased costs and more efficient resource use to pediatric subspecialty critical care. SUMMARY: As more becomes known regarding the impact of specialized ICU environments, pediatric surgical critical care, and pediatric surgical ICUs have the potential to improve the value of care delivered to these complex patients. Well-designed, prospective, observational studies are needed to assist in defining appropriate outcome and quality measures to inform the development of these specialized units. Currently, there are a variety of models used in children's hospitals to care for critically ill surgical patients. This represents a tremendous opportunity for a collaborative, multidisciplinary effort amongst pediatric medical and surgical intensivists.


Subject(s)
Critical Care/economics , Critical Illness/therapy , Intensive Care Units, Pediatric/economics , Pediatrics , Child , Humans , Surgery Department, Hospital
8.
Allergol Immunopathol (Madr) ; 48(2): 142-148, 2020.
Article in English | MEDLINE | ID: mdl-31601499

ABSTRACT

INTRODUCTION AND OBJECTIVES: With the aim of making informed decisions on resource allocation, there is a critical need for studies that provide accurate information on hospital costs for treating pediatric asthma exacerbations, mainly in middle-income countries (MICs). The aim of the present study was to evaluate the direct medical costs associated with pediatric asthma exacerbations requiring hospital attendance in Bogota, Colombia. PATIENTS AND METHODS: We reviewed the available electronic medical records (EMRs) for all pediatric patients who were admitted to the Fundacion Hospital de La Misericordia with a discharge principal diagnosis pediatric asthma exacerbation over a 24-month period from January 2016 to December 2017. Direct medical costs of pediatric asthma exacerbations were retrospectively collected by dividing the patients into four groups: those admitted to the emergency department (ED) only; those admitted to the pediatric ward (PW); those admitted to the pediatric intermediate care unit (PIMC); and those admitted to the pediatric intensive care unit (PICU). RESULTS: A total of 252 patients with a median (IQR) age of 5.0 (3.0-7.0) years were analyzed, of whom 142 (56.3%) were males. Overall, the median (IQR) cost of patients treated in the ED, PW, PIMC, and PICU was US$38.8 (21.1-64.1) vs. US$260.5 (113.7-567.4) vs. 1212.4 (717.6-1609.6) vs. 2501.8 (1771.6-3405.0), respectively: this difference was statistically significant (p<0.001). CONCLUSIONS: The present study helps to further our understanding of the economic burden of pediatric asthma exacerbations requiring hospital attendance among pediatric patients in a MIC.


Subject(s)
Asthma/economics , Health Care Costs , Hospitalization/economics , Adolescent , Child , Child, Preschool , Colombia , Emergency Service, Hospital/economics , Female , Humans , Intensive Care Units, Pediatric/economics , Length of Stay/economics , Male , Symptom Flare Up
9.
Acad Pediatr ; 20(3): 348-355, 2020 04.
Article in English | MEDLINE | ID: mdl-31254632

ABSTRACT

OBJECTIVE: To investigate the relationship between socioeconomic factors and bronchiolitis severity among hospitalized infants. METHODS: We performed a 17-center, prospective cohort study from 2011 to 2014. Children <1 year old hospitalized with bronchiolitis were enrolled. Socioeconomic factors included estimated median household income (MHI) per home ZIP code, parent-reported household income, number of adults and children in household, and insurance type. We defined higher bronchiolitis severity as receipt of intensive care treatment. Multivariable logistic regression was used to analyze the association between socioeconomic factors and bronchiolitis severity, with the final model adjusted for potential clustering by site. RESULTS: In multivariable models adjusted for demographic and clinical characteristics, estimated MHI was the socioeconomic factor most strongly associated with severity. Compared to infants with an intermediate MHI ($40,000-$79,999), odds of receiving intensive care treatment were significantly higher for those with MHI of ≥$80,000 (aOR 2.05, 95% CI 1.19-3.53). No significant associations were found for the other socioeconomic factors (all P > .30). While there were no significant differences in clinical presentation between income groups (all P > .25) or in receipt of mechanical ventilation alone (P = .98), infants with estimated MHI ≥$80,000 were significantly more likely to specifically have been admitted to the intensive care unit (P = .01). CONCLUSIONS: In this multicenter study of infants hospitalized with bronchiolitis, we identified higher median household income as a risk factor for intensive care treatment. This work may yield important biological or nonbiological insights for the future management of infants with bronchiolitis.


Subject(s)
Bronchiolitis/economics , Bronchiolitis/therapy , Hospitalization/statistics & numerical data , Income/statistics & numerical data , Intensive Care Units, Pediatric/economics , Intensive Care Units, Pediatric/statistics & numerical data , Female , Humans , Infant , Infant, Newborn , Male , Prospective Studies , Severity of Illness Index , Socioeconomic Factors , United States
10.
Pediatrics ; 144(6)2019 12.
Article in English | MEDLINE | ID: mdl-31676680

ABSTRACT

BACKGROUND: Disparities in health service use have been described across a range of sociodemographic factors. Patterns of PICU use have not been thoroughly assessed. METHODS: This was a population-level, retrospective analysis of admissions to the Cincinnati Children's Hospital Medical Center PICU between 2011 and 2016. Residential addresses of patients were geocoded and spatially joined to census tracts. Pediatric patients were eligible for inclusion if they resided within Hamilton County, Ohio. PICU admission and bed-day rates were calculated by using numerators of admissions and bed days, respectively, over a denominator of tract child population. Relationships between tract-level PICU use and child poverty were assessed by using Spearman's ρ and analysis of variance. Analyses were event based; children admitted multiple times were counted as discrete admissions. RESULTS: There were 4071 included admissions involving 3129 unique children contributing a total of 12 297 PICU bed days. Child poverty was positively associated with PICU admission rates (r = 0.59; P < .001) and bed-day rates (r = 0.47; P < .001). When tracts were grouped into quintiles based on child poverty rates, the PICU bed-day rate ranged from 23.4 days per 1000 children in the lowest poverty quintile to 81.9 days in the highest poverty quintile (P < .001). CONCLUSIONS: The association between poverty and poor health outcomes includes pediatric intensive care use. This association exists for children who grow up in poverty and around poverty. Future efforts should characterize the interplay between patient- and neighborhood-level risk factors and explore neighborhood-level interventions to improve child health.


Subject(s)
Healthcare Disparities/economics , Intensive Care Units, Pediatric/economics , Patient Admission/economics , Poverty/economics , Residence Characteristics , Child , Child, Preschool , Female , Healthcare Disparities/trends , Humans , Intensive Care Units, Pediatric/trends , Male , Ohio/epidemiology , Patient Admission/trends , Poverty/trends , Retrospective Studies
11.
Pediatr Crit Care Med ; 20(7): e301-e310, 2019 07.
Article in English | MEDLINE | ID: mdl-31162369

ABSTRACT

OBJECTIVES: Although several studies have reported outcome data on critically ill children, detailed reports by age are not available. We aimed to evaluate the age-specific estimates of trends in causes of diagnosis, procedures, and outcomes of pediatric admissions to ICUs in a national representative sample. DESIGN: A population-based retrospective cohort study. SETTING: Three hundred forty-four hospitals in South Korea. PATIENTS: All pediatric admissions to ICUs in Korea from August 1, 2009, to September 30, 2014, were covered by the Korean National Health Insurance Corporation, with virtually complete coverage of the pediatric population in Korea. Patients less than 18 years with at least one ICUs admission between August 1, 2009, and September 30, 2014. We excluded neonatal admissions (< 28 days), neonatal ICUs, and admissions for health status other than a disease or injury. The final sample size was 38,684 admissions from 32,443 pediatric patients. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: The overall age-standardized admission rate for pediatric patients was 75.9 admissions per 100,000 person-years. The most common primary diagnosis of admissions was congenital malformation (10,897 admissions, 28.2%), with marked differences by age at admission (5,712 admissions [54.8%] in infants, 3,994 admissions [24.6%] in children, and 1,191 admissions [9.9%] in adolescents). Injury was the most common primary diagnosis in adolescents (3,248 admissions, 27.1%). The overall in-hospital mortality was 2,234 (5.8%) with relatively minor variations across age. Neoplasms and circulatory and neurologic diseases had both high frequency of admissions and high in-hospital mortality. CONCLUSIONS: Admission patterns, diagnosis, management, and outcomes of pediatric patients admitted to ICUs varied by age groups. Strategies to improve critical care qualities of pediatric patients need to be based on the differences of age and may need to be targeted at specific age groups.


Subject(s)
Intensive Care Units, Pediatric/statistics & numerical data , Patient Admission/statistics & numerical data , Adolescent , Age Distribution , Cardiovascular Diseases/mortality , Cardiovascular Diseases/therapy , Child , Child, Preschool , Congenital Abnormalities/mortality , Congenital Abnormalities/therapy , Extracorporeal Membrane Oxygenation/statistics & numerical data , Female , Health Care Costs/statistics & numerical data , Hospital Mortality , Humans , Infant , Infections/mortality , Infections/therapy , Intensive Care Units, Pediatric/economics , Length of Stay/statistics & numerical data , Male , Musculoskeletal Diseases/mortality , Musculoskeletal Diseases/therapy , Neoplasms/mortality , Neoplasms/therapy , Nervous System Diseases/mortality , Nervous System Diseases/therapy , Patient Admission/economics , Renal Dialysis/statistics & numerical data , Republic of Korea/epidemiology , Respiration, Artificial/statistics & numerical data , Respiratory Tract Diseases/mortality , Respiratory Tract Diseases/therapy , Retrospective Studies , Vasoconstrictor Agents/therapeutic use , Wounds and Injuries/mortality , Wounds and Injuries/therapy
12.
Pediatr Int ; 61(7): 688-696, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31107995

ABSTRACT

BACKGROUND: We investigated the characteristics and clinical outcomes of respiratory syncytial virus (RSV)-related pediatric intensive care unit (PICU) hospitalization and assessed the palivizumab (PZ) prophylaxis eligibility according to different guidelines from Korea, EU, and USA. METHODS: In this multicenter study, children <18 years of age hospitalized in six PICU from different hospitals due to severe RSV infection between September 2008 and March 2013 were included. A retrospective chart review was performed. RESULTS: A total of 92 patients were identified. The median length of PICU stay was 6 days (range, 1-154 days) and median PICU care cost was USD2,741 (range, USD556-98 243). Of 62 patients who were <2 years old at the beginning of the RSV season, 33 (53.2%) were high-risk patients for severe RSV infection. Hemodynamically significant congenital heart disease (22.6%) was the most common risk factor, followed by chronic lung disease (11.3%), neuromuscular disease or congenital abnormality of the airway (NMD/CAA) (11.3%), and prematurity (8.1%). The percentage of patients eligible for PZ prophylaxis ranged from 38.7% to 48.4% based on the guidelines, but only two (2.2%) received PZ ≤30 days prior to PICU admission. The median duration of mechanical ventilation was longer in children with NDM/CAA than in those without risk factors (26 days; range, 24-139 days vs 6 days, range, 2-68 days, P = 0.033). RSV-attributable mortality was 5.4%. CONCLUSIONS: Children <2 years old with already well-known high risks represent a significant proportion of RSV-related PICU admissions. Increasing of the compliance for PZ prophylaxis practice among physicians is needed. Further studies are needed to investigate the burden of RSV infection in patients hospitalized in PICU, including children with NMD/CAA.


Subject(s)
Hospitalization , Intensive Care Units, Pediatric , Respiratory Syncytial Virus Infections , Respiratory Syncytial Virus, Human , Antiviral Agents/economics , Antiviral Agents/therapeutic use , Child , Child, Preschool , Female , Health Care Costs/statistics & numerical data , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Infant , Infant, Newborn , Intensive Care Units, Pediatric/economics , Intensive Care Units, Pediatric/statistics & numerical data , Linear Models , Logistic Models , Male , Palivizumab/economics , Palivizumab/therapeutic use , Practice Guidelines as Topic , Republic of Korea , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Virus Infections/economics , Respiratory Syncytial Virus Infections/etiology , Respiratory Syncytial Virus Infections/therapy , Retrospective Studies , Risk Factors , Seasons
13.
J Clin Virol ; 112: 15-19, 2019 03.
Article in English | MEDLINE | ID: mdl-30669024

ABSTRACT

BACKGROUND: Human metapneumovirus (HMPV) is a pneumovirus known to cause respiratory disease in children. It was identified as a pathogen in 2001 and its healthcare burden and associated costs are not fully understood. OBJECTIVES: This study aimed to assess the clinical characteristics of children with HMPV infection admitted to paediatric intensive care units (PICUs) across the United Kingdom (UK) over a nine-year period and to estimate the associated costs of care. STUDY DESIGN: Data were collected from the UK paediatric intensive care audit network (PICANet) and costs calculated using the National Health Service (NHS) reference costing scheme. RESULTS: There were 114 admissions in which HMPV was detected. The number of admissions associated with a code of HMPV rose steadily over the study period (three in 2006 to 28 in 2014) and showed significant seasonal variability, with the peak season being from November to May. Children required varying levels of intensive care support from minimal to complex support including invasive ventilation, inotropes, renal replacement therapy and extracorporeal membrane oxygenation (ECMO). HMPV was associated with five deaths during the study period. The associated costs of PICU admissions were estimated to be between £2,256,823 and £3,997,823 over the study period, with estimated annual costs rising over the study period due to increasing HMPV admissions. CONCLUSIONS: HMPV is associated with a significant healthcare burden and associated cost of care in PICUs in the UK.


Subject(s)
Hospitalization/statistics & numerical data , Intensive Care Units, Pediatric/statistics & numerical data , Paramyxoviridae Infections/epidemiology , Adolescent , Child , Child, Preschool , Cost of Illness , Female , Hospitalization/economics , Humans , Infant , Infant, Newborn , Intensive Care Units, Pediatric/economics , Male , Metapneumovirus/pathogenicity , National Health Programs/statistics & numerical data , Paramyxoviridae Infections/economics , Paramyxoviridae Infections/mortality , Retrospective Studies , Seasons , United Kingdom/epidemiology
14.
J Intensive Care Med ; 34(11-12): 973-977, 2019.
Article in English | MEDLINE | ID: mdl-28797189

ABSTRACT

OBJECTIVE: A child's pediatric intensive care unit (PICU) admission may have wide-ranging family implications. We assessed nonmedical out-of-pocket expenses (NMOOPEs) and disruptions in work and normal life for parents with a child admitted to the PICU for at least 2 days with acute, new onset, or exacerbation of a critical condition. DESIGN: We conducted a prospective, single-center study; administered a daily verbal response survey on NMOOPEs; stratified families by annual income (<$50 999, $51-99 000, >$100 000); and calculated daily expenditures (DEs), estimated daily budgets (DBs), and percentage of NMOOPEs (%DE/DB). We used a modified caregiver version of the Work Productivity and Activity Impairment Scale to assess the impact of PICU admission on work-related and normal life activities. SETTING: The PICU in an academic, tertiary medical center in the United States. PATIENTS: Patients admitted to PICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The study included 38 families, with median length of PICU stay of 3 days (range 3-13). The mean total NMOOPE was $127 ± $107 (range $5-$511). Financial impact of DB in the 3 annual income groups ranged from 0% to 136% (median 36%), 5% to 18% (median 10%), and 4% to 39% (median 16%), respectively. Total work absenteeism for cohort was 78 days. High levels of distraction were reported in working families, and normal daily activities were interrupted or suspended. CONCLUSIONS: PICU hospitalization results in a range of direct NMOOPEs of varying burden on families and additional work productivity impact. Further research to understand the array of financial implications on families and additional mitigation strategies are needed.


Subject(s)
Critical Illness/economics , Family Characteristics , Hospitalization/economics , Income/statistics & numerical data , Intensive Care Units, Pediatric/economics , Child , Child, Preschool , Cost of Illness , Female , Humans , Male , Pilot Projects , Prospective Studies , Qualitative Research
15.
Clin Pediatr (Phila) ; 58(2): 177-184, 2019 02.
Article in English | MEDLINE | ID: mdl-30387696

ABSTRACT

We reviewed the resource utilization of patients with human rhinovirus/enterovirus (HRV/ENT), influenza A/B (FLU), or respiratory syncytial virus (RSV). A total of 2013 patients with nasopharyngeal swabs positive for HRV/ENT, RSV, or FLU were included. Records were reviewed for respiratory support, vascular access procedures, emergency department care only versus admission versus pediatric intensive care unit (PICU) care, antibiotics, length of stay, and billing data. Of the 2013 subjects, 1251 tested positive for HRV/ENT, 558 for RSV, and 204 for FLU. Fewer HRV/ENT patients were discharged from the emergency department ( P < .001); and they were more likely to be admitted to the pediatric intensive care unit ( P < .001). HRV/ENT and RSV patients were more likely to require invasive procedures ( P = .01). Median hospital costs for HRV/ENT patients were more than twice that of FLU patients ( P < .001). HRV/ENT infection in pediatric patients poses a significant resource and cost burden, even when compared with other organisms.


Subject(s)
Enterovirus Infections/economics , Health Care Costs/statistics & numerical data , Health Resources/statistics & numerical data , Influenza, Human/economics , Picornaviridae Infections/economics , Respiratory Syncytial Virus Infections/economics , Child , Child, Preschool , Enterovirus Infections/therapy , Female , Humans , Infant , Influenza, Human/therapy , Intensive Care Units, Pediatric/economics , Length of Stay/statistics & numerical data , Male , Picornaviridae Infections/therapy , Respiratory Syncytial Virus Infections/therapy
16.
Pediatr Cardiol ; 40(1): 138-146, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30203291

ABSTRACT

The clinical benefit of early extubation following congenital heart surgery has been demonstrated; however, its effect on resource utilization has not been rigorously evaluated. We sought to determine the cost savings of implementing an early extubation pathway for children undergoing surgery for congenital heart disease. We performed a cost savings analysis after implementation of an early extubation strategy among children undergoing congenital heart surgery at British Columbia Children's Hospital (BCCH) over a 2.5-year period. All patients undergoing one of the eight Society of Thoracic Surgeons (STS) benchmark operations, ASD repair, or bidirectional cavopulmonary anastomosis were included in the analysis (n = 370). We compared our data to aggregate STS multi-institutional data from a contemporary cohort. We estimated daily costs for ICU care, ward care, medications, imaging, additional procedures, and allied health care using an administrative database. Direct costs, indirect costs, and cost savings were estimated. Simulation methods, Monte Carlo, and bootstrapping were used to calculate the 95% credible intervals for all estimates. The mean cost savings per procedure was $12,976 and the total estimated cost savings over the study period at BCCH was $4.8 million with direct costs accounting for 91% of cost savings. Sensitivity analysis demonstrated a mean cost savings range of $11,934-$14,059 per procedure. Early extubation is associated with substantial cost savings due to reduced hospital resource utilization. Implementation of an early extubation strategy following congenital heart surgery may contribute to improved resource utilization.


Subject(s)
Airway Extubation/economics , Cost Savings , Heart Defects, Congenital/surgery , Hospital Costs/statistics & numerical data , British Columbia , Child , Databases, Factual , Female , Humans , Infant , Intensive Care Units, Pediatric/economics , Male
17.
Int J Pediatr Otorhinolaryngol ; 115: 1-5, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30368366

ABSTRACT

OBJECTIVE: To assess the frequency of post-procedural complications, medical interventions, and hospital costs associated with microlaryngobronchoscopy (MLB) in children prophylactically admitted for pediatric intensive care unit (PICU) monitoring for age ≤ 2 years. METHODS: We performed a single-center, retrospective, descriptive study within a 44-bed PICU in a stand-alone, tertiary, pediatric referral center. Inclusion criteria were age ≤2 years and pre-procedural selection of prophylactic PICU monitoring after MLB between January 2010 and December 2015. Children were excluded for existing tracheostomy, if undergoing concurrent non-otolaryngeal procedures, or if intubated at the time of PICU admission. Primary outcomes were the development of major and minor procedural complications and medical rescue interventions. Secondary outcomes were hospital cost and length of stay (LOS). RESULTS: One hundred and eight subjects met inclusion criteria with a median age of 5.3 (IQR: 2.6-10.9) months. A majority (86%) underwent therapeutic instrumentation in addition to diagnostic MLB. There were no observed major complications or rescue interventions. Minor complications were noted within 5 h of monitoring and included isolated stridor (24%), desaturation <90% (10%), and nausea/emesis (8%). Minor interventions included supplemental oxygen via regular nasal cannula (39%), single-dose inhaled racemic epinephrine (19%), single-dose systemic corticosteroids (19%), or high flow nasal cannula (HFNC) therapy (4%). Save for two cases of HFNC, interventions were completed or discontinued within 5 h. Median PICU LOS was 1.1 days and median cost was $9650 (IQR: $8235- $14,861) per encounter. Estimated cost of same day observation in our post anesthesia care unit (PACU) following MLB without PICU admission is $1921 per encounter. CONCLUSIONS: In children ≤ 2 years of age prophylactically admitted for PICU observation, we did not observe severe complications or major interventions after MLB. Minor interventions and complications were noted early during post-procedural monitoring. PICU monitoring was substantially more expensive than same-day PACU observation. Young age as the sole criteria for prophylactic PICU monitoring after diagnostic or therapeutic MLB may be unjustified when comparable, cost-conscious care can be achieved in a PACU setting. Prior to pre-procedural selection of PICU monitoring, we recommend a broad contextual risk assessment including a review of comorbidities, operative plan, and intended anesthetic exposure.


Subject(s)
Bronchoscopy/adverse effects , Bronchoscopy/statistics & numerical data , Hospital Costs/statistics & numerical data , Intensive Care Units, Pediatric/statistics & numerical data , Laryngoscopy/adverse effects , Laryngoscopy/statistics & numerical data , Bronchoscopy/economics , Female , Humans , Infant , Intensive Care Units, Pediatric/economics , Laryngoscopy/economics , Length of Stay/economics , Length of Stay/statistics & numerical data , Male , Postoperative Complications/etiology , Postoperative Complications/therapy , Retrospective Studies
18.
Hosp Pediatr ; 8(6): 361-367, 2018 06.
Article in English | MEDLINE | ID: mdl-29794122

ABSTRACT

OBJECTIVES: To describe asthma management, investigate practice variation, and describe asthma-associated charges and resource use during asthma management in the PICU. METHODS: Children ages 2 to 18 years treated for status asthmaticus in the PICU from 2008 to 2011 are included in this study. This is a retrospective, single-center, cohort study. Data were collected by using the Intermountain Healthcare Enterprise Data Warehouse. RESULTS: There were 262 patients included and grouped by maximal respiratory support intervention. Seventy percent of the patients did not receive escalation of respiratory support beyond nasal cannula or nonrebreather mask, and the majority of these patients received only first-tier recommended therapy. For all patients, medical imaging and laboratory charge fractions accounted for <3% and <5% of the total charges, respectively. Among nonintubated patients, the majority of these diagnostic test results were normal. Fifteen patients were intubated during our study period; 4 were intubated at our facility. Compared with outside hospital intubations, these 4 patients had longer time to intubation (>3 days versus <24 hours) and significantly longer median PICU length of stay (12.7 days versus 2.6 days). CONCLUSIONS: In our study, the vast majority of patients with severe asthma were treated with minimal interventions alone (nasal cannula or nonrebreather mask and first-tier medications). Minimizing PICU length of stay is likely the most successful way to decrease expense during asthma care.


Subject(s)
Asthma/therapy , Intensive Care Units, Pediatric , Length of Stay/statistics & numerical data , Adolescent , Asthma/economics , Asthma/epidemiology , Child , Child, Preschool , Cost-Benefit Analysis , Databases, Factual , Female , Humans , Intensive Care Units, Pediatric/economics , Intubation, Intratracheal/economics , Male , Respiration, Artificial/economics , Retrospective Studies , United States/epidemiology
19.
Int J Clin Pharm ; 40(3): 513-519, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29603074

ABSTRACT

Background Problems related to pharmacotherapy are common in patients admitted to the paediatric intensive care unit (PICU) and are associated with increased healthcare costs. Data on the impact of clinical pharmacist interventions to prevent pharmacotherapy-related problems and to minimize costs in the PICU are limited. Objectives To evaluate the number and type of clinical pharmacist interventions in the PICU and to determine cost savings associated with them. Setting a ten bed PICU of a tertiary-care university hospital in Brazil. Method This was a prospective, observational study conducted over 1-year. The Failure Mode and Effects Analysis (FMEA) tool was applied at the beginning of the study to assess drug-related risks in the PICU and to guide clinical pharmacist interventions. Main outcome measure Number and type of clinical pharmacist interventions and healthcare-related costs. Results One hundred sixty-two children were followed-up by the clinical pharmacist and 1586 prescriptions were evaluated; pharmacotherapy-related problems were identified in 12.4% of them. Sixteen of 75 failure modes identified by FMEA were potentially reduced by the clinical pharmacist interventions. There were 197 interventions with a cost saving of R$ 15,118.73 (US$ 4828.00). Clinical pharmacist interventions were related to drug interaction and therapeutic monitoring (34.5%), drug selection (22.3%), dosing and frequency (16.8%), prescription (13.2%) and administration (13.2%). Ninety-seven per cent of the clinical pharmacist interventions were accepted by the medical team. The interventions with larger cost savings were related to administration (39%). Conclusion The clinical pharmacist interventions minimized the risks of pharmacotherapy-related problems and contributed to the reduction of costs associated with medical prescription.


Subject(s)
Health Care Costs/statistics & numerical data , Intensive Care Units, Pediatric/economics , Medication Errors/economics , Medication Errors/prevention & control , Pharmacy Service, Hospital/economics , Pharmacy Service, Hospital/statistics & numerical data , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...